Colitis ulcerative
Not recruitingStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
- Disease:Colitis ulcerative
- Substances:–
France- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to France61 clinical trials in Neuilly-Sur-Seine, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on inflammatory bowel diseases, particularly investigating innovative treatments for Crohn's Disease and Ulcerative Colitis. Multiple studies are evaluating novel therapeutic approaches for patients with moderate to severe conditions.
Research includes both induction and maintenance therapies, with emphasis on long-term patient outcomes.
Innovative research in cardiac conditions, including studies on acute myocarditis treatment and prevention of post-operative complications. Trials are examining both therapeutic and preventive approaches.
Focus on improving patient outcomes through targeted interventions and innovative surgical techniques.
Advanced studies in cancer treatment, including trials for head and neck squamous cell carcinoma and colorectal cancer. Research focuses on both targeted therapies and combination treatments.
Emphasis on developing personalized treatment approaches and improving survival rates.
Tell us about your condition – we search every trial in Europe and connect you with the right site.